Latest News and Press Releases

September 19, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical...

May 15, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Total Voting Rights Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage...

VEON announces the issuance of previously authorized shares representing approximately 4.99% of total share capital Amsterdam, 1 March 2024 15:00 CET  – VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam:...

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and...

FUZHOU, China, Sept. 28, 2022 (GLOBE NEWSWIRE) -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the “Company” or “E-Home”), a provider of integrated household services in China, today...

TORONTO, June 16, 2021 (GLOBE NEWSWIRE) -- Research Capital Corporation (formerly Mackie Capital Corporation) has exercised all of its 1,355,940 broker compensation option units (CPU), said Amarillo...

SCANFIL OYJ PÖRSSITIEDOTE 28.5.2021 KLO 13.00 Scanfil Oyj:n (”Yhtiö” tai ”Scanfil”) optio-oikeuksilla 2016C on 5.5. ja 18.5.2021 merkitty yhteensä 130 000 Yhtiön uutta osaketta. Optio-oikeuksilla...

SCANFIL PLC STOCK EXCHANGE RELEASE 28 MAY 2021 1.00 P.M. On 5 and 18 May 2021, a total of 130,000 Scanfil plc’s (the "Company" or "Scanfil") new shares have been subscribed for with the Company's...

  Geneva, Switzerland and Boston, MA – Thursday 11 February, 2021 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and...